(c) 2024 PillSync.com

Finasteride 1 MG Oral Tablet

1 INDICATIONS AND USAGE Finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY . Efficacy in bitemporal recession has not been established. Finasteride tablets are not indicated for use in women. Finasteride is a 5α-reductase inhibitor indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY ( 1 ). Finasteride tablets are not indicated for use in women ( 1 , 4 , 5.1 ).

accord healthcare, inc.


5 years ago ROUND BROWN F1 Finasteride 1 MG Oral Tablet

ROUND BROWN F1

16 HOW SUPPLIED/STORAGE AND HANDLING

FINASTERIDE tablets, USP 1 mg: reddish brown, 7 mm, round, biconvex, film coated tablets, marked ‘F1’ on one side and plain on other side. They are supplied as follows: NDC 16729-089-10 Bottle of 30 with child resistant closure (with desiccant) NDC 16729-089-15 Bottle of 90 with child resistant closure (with desiccant). Storage and Handling Store at 20º to 25 ºC (68 º to 77 ºF) [See USP controlled room temperature]. Keep container closed and protect from moisture. Women should not handle crushed or broken

FINASTERIDE tablets when they are pregnant or may potentially be pregnant because of the possibility of absorption of

FINASTERIDE and the subsequent potential risk to a male fetus.

FINASTERIDE tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed [see Warnings and Precautions (5.1) , Use in Specific Populations (8.1) and Patient Counseling Information (17) ] .


More pills like ROUND F1












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site